APA

Delmas P. D., McClung M. R., Zanchetta J. R., Racewicz A., Roux C., Benhamou C., Man Z., Eusebio R. A., Beary J. F., Burgio D. E., Matzkin E. & Boonen S. (20080403). Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. : Bone.

Chicago

Delmas Pierre D, McClung Michael R, Zanchetta José R, Racewicz Artur, Roux Christian, Benhamou Claude-Laurent, Man Zulema, Eusebio Rachelle A, Beary John F, Burgio David E, Matzkin Ellen and Boonen Steven. 20080403. Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. : Bone.

Harvard

Delmas P. D., McClung M. R., Zanchetta J. R., Racewicz A., Roux C., Benhamou C., Man Z., Eusebio R. A., Beary J. F., Burgio D. E., Matzkin E. and Boonen S. (20080403). Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. : Bone.

MLA

Delmas Pierre D, McClung Michael R, Zanchetta José R, Racewicz Artur, Roux Christian, Benhamou Claude-Laurent, Man Zulema, Eusebio Rachelle A, Beary John F, Burgio David E, Matzkin Ellen and Boonen Steven. Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. : Bone. 20080403.